A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine

A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine

IntroductionFor complete or functional cure of hepatitis B virus (HBV) infection, application of immunotherapy is now being attempted. Recently, we reported that a 6-mer hepatitis B virus (HBV)-derived peptide, Poly6, exerts a strong anticancer effect in tumor-implanted mice through inducible nitric...

Full description

Bibliographic Details
Main Authors: Yu-Min Choi, Dong Hyun Kim, Junghwa Jang, Bum-Joon Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
hepatitis B virus (HBV)
therapeutic vaccination
adjuvant
type 1 interferon (IFN-I)
(HBV)-derived peptide
Poly6
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1155637/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1155637/full

Similar Items